3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.60
-1.30 (-3.62%)
Apr 29, 2026, 1:25 PM CST
-34.22%
Market Cap 2.76B
Revenue (ttm) 206.74M
Net Income (ttm) 66.53M
Shares Out 76.98M
EPS (ttm) 0.84
PE Ratio 42.74
Forward PE n/a
Dividend 0.10 (0.28%)
Ex-Dividend Date n/a
Volume 55,896
Average Volume 155,671
Open 36.00
Previous Close 35.90
Day's Range 34.40 - 36.00
52-Week Range 30.15 - 63.00
Beta 0.30
RSI 56.94
Earnings Date Apr 30, 2026

About 3D Global Biotech

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 43
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

In 2025, 3D Global Biotech's revenue was 206.74 million, a decrease of -22.19% compared to the previous year's 265.69 million. Earnings were 66.53 million, a decrease of -27.45%.

Financial Statements

News

There is no news available yet.